Ionis Pharmaceuticals (IONS) News Today → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Free IONS Stock Alerts $44.66 +0.55 (+1.25%) (As of 03/27/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIonis to hold olezarsen Phase 3 data webcastprnewswire.com - March 28 at 7:05 AMARK Investment Management LLC Sells 461,311 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - March 28 at 6:39 AMPositive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meetingprnewswire.com - March 25 at 8:18 AMIonis Pharmaceuticals (IONS) Down 2.8% Since Last Earnings Report: Can It Rebound?finance.yahoo.com - March 22 at 4:41 PMWellington Management Group LLP Raises Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - March 19 at 4:53 AMIONS Oct 2024 50.000 putca.finance.yahoo.com - March 17 at 9:00 PMNASH drug market expected to surpass $48B by 2035msn.com - March 16 at 1:30 PMIONS Apr 2024 75.000 callfinance.yahoo.com - March 16 at 8:29 AMQ4 2023 Agenus Inc Earnings Call and Corporate Updatefinance.yahoo.com - March 14 at 10:45 PMAnalysts Offer Insights on Healthcare Companies: Chemed (CHE), Ionis Pharmaceuticals (IONS) and Arcellx Inc (ACLX)markets.businessinsider.com - March 14 at 10:45 PMMadrigal wins FDA approval of first drug for MASHfinance.yahoo.com - March 14 at 5:44 PMHudson Bay Capital Management LP Has $8.62 Million Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - March 14 at 7:25 AMGenetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Showsbenzinga.com - March 13 at 12:50 PMIonis Pharma's fatty liver disease drug succeeds in mid-stage trialreuters.com - March 13 at 7:50 AMIonis announces positive results from Phase 2 study of ION224, an investigational medicine demonstrating clinical efficacy in the treatment of NASH/MASHfinance.yahoo.com - March 13 at 7:50 AMJacobs Levy Equity Management Inc. Sells 176,441 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - March 12 at 8:39 AMCytokinetics drifts lower as CEO touts standalone strategymsn.com - March 11 at 5:47 PMAre These 5 Undervalued Stocks Ready to Break Out?marketbeat.com - March 8 at 9:11 AMAre These 5 Undervalued Stocks Ready to Break Out? (IONS)marketbeat.com - March 8 at 9:10 AMEnvestnet Asset Management Inc. Increases Stock Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - March 7 at 4:38 AMIonis Pharmaceuticals price target raised by $7 at Oppenheimer, here's whyrealmoney.thestreet.com - March 6 at 7:51 PMTD Cowen Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)markets.businessinsider.com - March 6 at 7:51 PMIonis Pharmaceuticals (NASDAQ:IONS) Price Target Increased to $72.00 by Analysts at Oppenheimermarketbeat.com - March 6 at 9:45 AMAdage Capital Partners GP L.L.C. Invests $48.40 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - March 5 at 1:20 PMIonis announces new chief global product strategy officer to lead next phase of commercial growthprnewswire.com - February 29 at 9:05 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Stifel Financial Corpmarketbeat.com - February 29 at 6:14 AMIonis to present at upcoming investor conferencesprnewswire.com - February 28 at 7:05 AMTrexquant Investment LP Raises Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - February 27 at 9:57 AMIonis Pharmaceuticals (NASDAQ:IONS) Earns "Outperform" Rating from Oppenheimermarketbeat.com - February 26 at 9:32 AMConnor Clark & Lunn Investment Management Ltd. Has $5.89 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - February 26 at 8:19 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Just Released Its Yearly Results And Analysts Are Updating Their Estimatesfinance.yahoo.com - February 24 at 11:43 AMIonis Pharmaceuticals 2023 Earnings Review: Short-Term Pain, Long-Term Gainseekingalpha.com - February 23 at 5:58 PMEAM Investors LLC Acquires New Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - February 23 at 8:47 AMIonis Pharmaceuticals Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - February 23 at 7:43 AM2IONS : Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticalsbenzinga.com - February 22 at 9:42 PMIonis Pharmaceuticals, Inc.: Ionis Earnings: Maintaining $62 Fair Value Estimate; Wainua a Precursor to Two Independent Launchesfinance.yahoo.com - February 22 at 9:42 PMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 22 at 2:15 PMCracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticalsmarkets.businessinsider.com - February 22 at 9:15 AMQ4 2023 Ionis Pharmaceuticals Inc Earnings Callfinance.yahoo.com - February 22 at 9:15 AMIonis Pharmaceuticals (NASDAQ:IONS) Rating Reiterated by Needham & Company LLCmarketbeat.com - February 22 at 8:12 AMIonis Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 21 at 4:47 PMIonis Pharmaceuticals (IONS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimatesfinance.yahoo.com - February 21 at 2:47 PMClearbridge Investments LLC Sells 346,509 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - February 21 at 10:48 AMIonis Pharmaceuticals, Inc.: Ionis reports fourth quarter and full year 2023 financial resultsfinanznachrichten.de - February 21 at 9:47 AMIonis reports fourth quarter and full year 2023 financial resultsfinance.yahoo.com - February 21 at 9:47 AMIonis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimatesfinance.yahoo.com - February 21 at 9:47 AMIonis Pharmaceuticals (NASDAQ:IONS) Issues Earnings Resultsmarketbeat.com - February 21 at 8:26 AMIonis reports fourth quarter and full year 2023 financial resultsprnewswire.com - February 21 at 7:00 AMIonis Pharmaceuticals FY 2023 Earnings Previewmsn.com - February 20 at 2:31 PMIONS Mar 2024 40.000 putfinance.yahoo.com - February 19 at 10:14 AM Get Ionis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter. Email Address Major Elon Musk Crypto Leak Revealed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. IONS Media Mentions By Week IONS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IONS News Sentiment▼0.370.61▲Average Medical News Sentiment IONS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IONS Articles This Week▼45▲IONS Articles Average Week Get Ionis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MDGL News Today ALKS News Today FOLD News Today GERN News Today DVAX News Today UTHR News Today TEVA News Today BMRN News Today ALNY News Today ITCI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IONS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.